FACTORS ASSOCIATED WITH NONADHERENCE TO HORMONAL CONTRACEPTIVE USE IN WOMEN OF REPRODUCTIVE AGE
Article Sidebar
Main Article Content
Abstract
Introduction: Therapeutic adherence is the degree to which a patient's behavior follows medical instructions regarding taking medication. Discontinuing hormonal contraceptive treatment impacts effectiveness, leading to unwanted pregnancies. Objective: To analyze the published scientific evidence on factors related to lack of adherence to the use of hormonal contraceptive methods in women of reproductive age. Methods: Research guided by the guidelines of the Joanna Briggs Institute (JBI) Manual, in accordance with the PRISMA -ScR guide for scoping reviews, with a search in some databases such as PubMed, Scopus, LILACS, SciELO and Google Scholar. The selection of evidence was individualized, carried out by two reviewers using RAYYAN software, with activated blinding, with analysis of studies with quantitative and qualitative methodological designs. There were no restrictions regarding language or publication date. The variables analyzed were: use of hormonal contraceptives in women of reproductive age and factors associated with lack of adherence. A total of 15 studies were included for the review. Results: It was established that lack of adherence is associated with factors inherent to the patient (age, level of education, forgetfulness, economic resources, beliefs), to the therapy (side effects) and to the relationship between health personnel and the health system (counseling). Conclusions: These factors must be addressed from public health policies to ensure adequate adherence and safe use of hormonal contraception.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Organización mundial de la salud [OMS]. Adherencia a los tratamientos a largo plazo: Pruebas para la acción. 2004. p. 1–198. Disponible en: https://www3.paho.org/spanish/ad/dpc/nc/nc-adherencia.htm
Manchikanti A, Fuentes L, Allina A. ¿Mujeres o LARC primero? Autonomía reproductiva y promoción de métodos anticonceptivos reversibles de larga duración. Reproductive Autonomy and LARC Promotion. 2014;46(3):171–175. DOI: https://doi.org/10.1363/46e1614
Gutierrez H, Huamán Carhuas L, Cehua Alvarez EA, Matzumura Kasano JP, Valdeiglesias Ochoa D. Adherencia y barreras en el uso de anticonceptivos en mujeres adultas jóvenes atendidas en establecimientos de salud del primer nivel de atención, Perú. Medicina Clínica y Social. 2023;7(2):84–94. DOI: https://doi.org/10.52379/mcs.v7i2.283
Organización mundial de la salud [OMS]. Planificación familiar/métodos anticonceptivos. 2023. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/family-planning-contraception
Statista. Ranking de los países con menor acceso a métodos anticonceptivos modernos en Europa en 2023. Disponible en: https://es.statista.com/estadisticas/611567/paises-europeos-con-menos-acceso-a-metodos-de-planificacion-familiar/
Fondo de Población de las Naciones Unidas [UNFPA]. Planificación Familiar. 2023. Disponible en: https://lac.unfpa.org/es/temas/planificaci%C3%B3n-familiar#:~:text=La%20tasa%20de%20prevalencia%20de,anticonceptivos%20modernos%20es%20de%2067%25.
Fondo de Población de las Naciones Unidas [UNFPA].. Evaluación Final del VII Programa de País (2019 – 2022) del Fondo de Población de las Naciones Unidas en Ecuador. 2022. Disponible en: https://www.unfpa.org/evaluacion-del-vii-programa-de-pais-2019-2022-del-fondo-de-poblacion-de-las-naciones-unidas-en#:~:text=La%20Evaluación%20del%20VII%20Programa,dinámica%20poblacional%2C%20en%20contextos%20de
Adarve E, Falguera G, Seguranyes G. Adherencia y cumplimiento del método anticonceptivo hormonal oral. Matronas Profesión. 2016;17(1):28–34. Disponible en: http://hdl.handle.net/2445/145263
Arksey, O’Malley. Estudios de alcance: hacia un marco metodológico. Revista Internacional de Metodología de la Investigación Social. 2005;8(1):19–32. DOI: https://doi.org/10.1080/1364557032000119616
Joanna Briggs Institute. Chapter 11: Scoping reviews. In: JBI Manual for Evidence Synthesis. JBI; 2020. Disponible en: https://jbi.global/scoping-review-network/resources
Tricco A, Lillie E, Zarin W, O’Brien K, Colquhoun H, Danielle Levac, et al. Extensión PRISMA para revisiones de alcance (PRISMA-ScR): lista de verificación y explicación. Ann Intern Med. 2018;169(7):467–473. DOI: https://doi.org/10.7326/M18-0850.
Preferred Reporting Items for Systematic reviews and Meta-Analyses [PRISMA]. Flow Diagram. 2020. Disponible en: http://www.prisma-statement.org/PRISMAStatement/FlowDiagramhttp://www.prisma-statement.org/PRISMAStatement/FlowDiagram
Pollock, Micah D.J. Peters, Hanan Khalil, Patricia McInerney, Lyndsay Alexander, Andrea C. Tricco, et al. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth. 2023;21(3):520–532. Disponible en: file:///C:/Users/HP/Desktop/recommendations_for_the_extraction,_analysis,_and.7%20(1).pdf
Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–115. DOI: https://doi.org/10.1111/j.1365-2648.2007.04569.x.
Al-Ghashri F, Al-Harthi H, Al Shukri M, Al Shidhani A. Discontinuation of hormonal contraception in Oman: prevalence and reasons. Eastern Mediterranean Health Journal. 2021;27(10):993–1000. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34766325/
González E, Molina b T, Montero A, Martínez V, Molina R. Factores asociados a la continuidad del uso anticonceptivo en adolescentes solteras nulíparas. Rev Med Chil. 2009;137(9). DOI: http://dx.doi.org/10.4067/S0034-98872009000900007
Mesha M, Alemayehu A, Daka D. Prevalence and factors associated with early discontinuation rate of Implanon utilization among women who ever used Implanon in Kucha District Gamo Gofa Zone, Southern Ethiopia. BMC Womens Health. 2020;20(1):239. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33097056/
Vásquez E, Brenda N. Factores asociados al abandono de los implantes hormonales subdérmicos atendidos en el Hospital Regional de Ica 2014 - 2016. [ICA - PERÚ]: Universidad Alas Peruanas; 2016. Disponible en: https://hdl.handle.net/20.500.12990/3714
D’Antona Á de O, Chelekis JA, D’Antona MFL de T, Siqueira AD. Contraceptive discontinuation and non-use in Santarém, Brazilian Amazon. Cad Saude Publica. 2009;25(9):2021–2032. DOI: https://doi.org/10.1590/s0102-311x2009000900016
Borges ALV, Chofakian CB do N, Viana OA, Divino E do A. Descontinuidades contraceptivas no uso do contraceptivo hormonal oral, injetável e do preservativo masculino. Cad Saude Publica. 2021;37(2). Disponible en: https://pubmed.ncbi.nlm.nih.gov/33624693/
Panduro K. Factores relacionados al abandono de métodos anticonceptivos hormonales en usuarias atendidas en el centro de salud Supte San Jorge. [Huánuco - Perú]: Universidad de Huánuco; 2021. Disponible en: http://repositorio.udh.edu.pe/123456789/3023
Maceira D, Oizerovich S, Perrotta G, de León RGP, Karolinski A, Suarez N, et al. Acceptability and continuation of use of the subdermal contraceptive implant among adolescents and young women in Argentina: a retrospective cohort study. Sex Reprod Health Matters. 2023;31(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/37042700/
Simmons RG, Sanders JN, Geist C, Gawron L, Myers K, Turok DK. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants. Am J Obstet Gynecol. 2019;220(4):376.e1-376.e12. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30576664/
Souza JMM de Pelloso SM, Uchimura NS, Souza F de. Utilização de métodos contraceptivos entre as usuárias da rede pública de saúde do município de Maringá-PR. Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(5):271–277. DOI: https://doi.org/10.1590/S0100-72032006000500002
Izale K, Govender I, Fina JPL, Tumbo J. Factors that influence contraceptive use amongst women in Vanga health district, Democratic Republic of Congo. Afr J Prim Health Care Fam Med. 2014;6(1): E1-7. DOI: https://doi.org/10.4102/phcfm.v6i1.599.
Hidalgo M, Nardiz M. Anticonceptivos hormonales. Farmacia Profesional. 2014;28(3):28–33. Disponible en: https://www.elsevier.es/es-revista-farmacia-profesional-3-articulo-anticonceptivos-hormonales-X0213932414316911
Yaremenko F. Anticonceptivos hormonales. Rev Obstet Ginecol. 2016;76(1):85–88. Disponible en: https://ve.scielo.org/pdf/og/v76s1/art14.pdf
Sociedad Española de Farmacia Familiar y Comunitaria [SEFAC]. Dispensación, adherencia y uso adecuado del tratamiento guía práctica para el farmacéutico comunitario. EDITTEC. 2017. 1–64 p. Disponible en: https://www.sefac.org/sites/default/files/2017-11/Adherencia_0.pdf
Çalıkoğlu E, Bilge E, Kavuncuoğlu D, Yılmaz S, Koşan Z, Aras A. Use of Family Planning Methods and Influencing Factors Among Women in Erzurum. Med Sci Monit. 2018; 24: 5027–5034. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30024863/
Najan A, Dixit P, Bhalerao A. The Acceptance of Postpartum Intrauterine Contraceptive Devices Among Women Who Receive Focused Family Planning Counseling in the Antenatal Period Compared to Those Who Receive Routine Counseling: A Randomized Controlled Trial. Cureus. 2023;15(6):1–10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338990/
Karadon D, Esmer Y, Okcuoglu B, Kurutas S, Baykal S, Huber S, et al. Understanding family planning decision-making: perspectives of providers and community stakeholders from Istanbul. BMC Womens Health. 2021;21(1):1–10. DOI: https://doi.org/10.1186/s12905-021-01490-3
Iijima S, Yokoyama K. Socioeconomic Factors and Policies Regarding Declining Birth Rates in Japan. Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene). 2018;73(3):305–312. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30270298/
Johnson AZ, Sieving RE, Pettingell SL, McRee AL. The Roles of Partner Communication and Relationship Status in Adolescent Contraceptive Use. Journal of Pediatric Health Care. 2015;29(1):61–69. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25150381/
Karaoğlan D, Saraçoğlu DŞ. Women’s socioeconomic status and choice of birth control method: an investigation for the case of Turkey. J Biosoc Sci. 2021;53(1):137–156. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32157984/
Congy J, Bouyer J, de La Rochebrochard E. Low-income women and use of prescribed contraceptives in the context of full health insurance coverage in France, 2019. Contraception. 2023; 121: 109976. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36758736/
Tampah-Naah AM, Yendaw E, Sumankuuro J. Residential status and household wealth disparities in modern contraceptives use among women in Ghana: a cross-sectional analysis. BMC Womens Health. 2023;23(1):550. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37875940/
Barrera L, Olvera V, Castelo C, Cancelo M. Causas de desapego a los métodos anticonceptivos. Ginecol Obstet Mex. 2019; 1:128–135. Disponible en: https://diposit.ub.edu/dspace/bitstream/2445/138425/1/690779.pdf
Mørch L, Skovlund C, Hannaford P, Iversen L, Fielding S, Lidegaard Ø. Contemporary Hormonal Contraception and the Risk of Breast Cancer. N Engl J Med. 2017; 377 (23): 2228–2239. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29211679/
Ortiz L, Juárez A, Calixto H. Factores asociados al apego de anticonceptivos orales en usuarias del centro de salud Pedro Escobedo. Revista Científica de Enfermería. 2022; 23: 6–17. Disponible en: https://recien.ua.es/article/view/22568
Cooper DB, Patel P, Mahdy H. Oral Contraceptive Pills. 2024. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28613632/
Le Guen M, Schantz C, Régnier-Loilier A, de La Rochebrochard E. Reasons for rejecting hormonal contraception in Western countries: A systematic review. Soc Sci Med. 2021; 284: 114247. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34339927/
Pizarro E, Galán G, Lavín P, Benavides C, Rivera F. Estudio PIENSA: efecto de la asesoría sobre la elección de anticonceptivos hormonales combinados en mujeres chilenas. Rev Chil Obstet Ginecol. 2014; 79 (5) :361–367. Disponible en: https://www.scielo.cl/scielo.php?pid=S0717-75262014000500002&script=sci_arttext
Rodriguez MI, Hersh A, Anderson LB, Hartung DM, Edelman AB. Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs. Obstetrics & Gynecology. 2019; 133 (6): 1238–1246. DOI: https://doi.org/10.1097/AOG.0000000000003265